Cancel
Known information
- Co-inventor of the technology platform developed to produce Clene’s Clean-Surface Nanocrystal (CSN™) therapeutics
- Inventor/co-inventor for 30 other U.S. patents and hundreds of corresponding foreign patents
- Former Chief Operating Officer of Research, Development and Manufacturing for an advanced materials-based company of more than 300 employees
- Former chief patent counsel responsible for approximately 5,500 patents and patent applications in the U.S. and 44 foreign countries
- Holds a Bachelor of Science in physics and a Bachelor of Science in ceramic engineering from Alfred University
- Holds a Master of Science in material science from Pennsylvania State University
- Holds a Juris Doctor degree from George Washington University
About Clene Nanomedicine
Clene Nanomedicine is a biopharmaceutical company focused on developing nanotherapeutics for neurodegenerative diseases, with its lead candidate, CNM-Au8, targeting ALS, MS, and Parkinson's Disease.
Report inaccurate information
